Efstathios "Stathis� Karathanasis, PhD and William Schiemann, PhD are leading a team of researchers from the Case Comprehensive Cancer Center (Case CCC) and Duke University combining nanotechnology with immunotherapy to treat metastatic breast cancer. The team received a five-year, $3M grant from the National Cancer Institute to continue research into the engineering of nanoparticles that can wake up “cold� tumors so they can be located and attacked by the immune system.
The research team includes: Efstathios Karathanasis, PhD, an associate professor of biomedical engineering, Case Western Reserve University (CWRU) and member of the Cancer Imaging Program, Case CCC; William Schiemann, PhD, the Goodman-Blum Professor in Cancer Research, CWRU and member of the Molecular Oncology Program, Case CCC; Li Lily Wang, PhD, associate staff, Cleveland Clinic Lerner Research Institute and Member, Hematopoietic and Immune Cancer Biology Program, Case CCC; and Christopher Hoimes, MD, Duke University School of Medicine.